The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
Abstract
OBJECTIVE: Treatment efficacy in schizophrenia is typically defined in terms of symptom reduction. However, new antipsychotic medications could potentially have an impact on aspects of disability, such as neurocognitive deficits. The authors evaluated the effects of risperidone on verbal working memory, a memory component of theoretical interest because of its link to prefrontal activity and of practical interest because of its link to psychosocial rehabilitation. METHOD: Verbal working memory of 59 treatment-resistant schizophrenic patients was assessed as part of a randomized, double-blind comparison of treatment with risperidone and haloperidol. Verbal working memory was measured under both distracting and nondistracting conditions at baseline and after 4 weeks of both fixed- and flexible-dose pharmacotherapy. RESULTS: Risperidone treatment had a greater beneficial effect on verbal working memory than haloperidol treatment across testing conditions (with and without distraction) and study phases (fixed and flexible dose). The treatment effect remained significant after the effects of benztropine cotreatment, change in psychotic symptoms, and change in negative symptoms were controlled. Neither benztropine status nor symptom changes were significantly related to memory performance. CONCLUSIONS: Treatment with risperidone appears to exert a more favorable effect on verbal working memory than treatment with a conventional neuroleptic. The beneficial effect appears to be due, at least partially, to a direct effect of the drug, possibly through antagonism of the 5-HT2A receptor. Results from this study suggest that pharmacotherapeutic efficacy in schizophrenia treatment could be broadened to include impact on neurocognitive abilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Baddeley, A. (1992) · Science · doi:10.1126/science.1736359 · Cited by 5,258
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Self-citationHuman Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
Unbalanced Repeated-Measures Models with Structured Covariance Matrices
Jennrich, R. I., & Schluchter, M. D. (1986) · Biometrics · doi:10.2307/2530695 · Cited by 1,325
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Spence, S. (1996) · BMJ · doi:10.1136/bmj.312.7024.193 · Cited by 1,164
Petrides, M., Alivisatos, B., Meyer, E., & Evans, A. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.878 · Cited by 898
Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters."
Ventura, J., Green, M. F., Shaner, A. L., & Liberman, R. P. (1993) · International Journal of Methods in Psychiatric Research · Cited by 748
Activation of the prefrontal cortex in a nonspatial working memory task with functional MRI
Cohen, J. D., Forman, S. D., Braver, T. S., Casey, B. J., Servan‐Schreiber, D., & Noll, D. C. (1994) · Human Brain Mapping · doi:10.1002/hbm.460010407 · Cited by 576
Analysis of Covariance: Its Nature and Uses
Cochran, W. G. (1957) · Biometrics · doi:10.2307/2527916 · Cited by 504
Memory and frontal lobe function.
Shimamura, A. P. (1995) · Cited by 423
Hagger, C., Buckley, P., Kenny, J. T., Friedman, L., Ubogy, D., & Meltzer, H. Y. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90043-d · Cited by 393
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
Spohn, H. E., & Strauss, M. E. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.4.367 · Cited by 381
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
Goldberg, T. E., Greenberg, R. D., Griffin, S. J., Gold, J. M., Kleinman, J. E., Pickar, D., Schulz, S. C., & Weinberger, D. R. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.43 · Cited by 289
Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281
Neuroleptics: Effects on Neuropsychological Function in Chronic Schizophrenic Patients
Cassens, G., Inglis, A. K., Appelbaum, P. S., & Gutheil, T. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.477 · Cited by 271
Major Psychiatric Disorders: A Four-Dimensional Model
Overall, J. E. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730200014003 · Cited by 253
Oltmanns, T. F., & Neale, J. M. (1975) · Journal of Abnormal Psychology · doi:10.1037/h0076721 · Cited by 243
Altman, H. J., & Normile, H. J. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80124-6 · Cited by 181
Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1460 · Cited by 173
Preclinical pharmacology of neuroleptics: focus on new generation compounds.
Richelson, E. (1996) · PubMed · Cited by 135
Hoff, A. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00242-6 · Cited by 133
Memory deficits and anticholinergic levels in chronic schizophrenia
PERLICK, D. A., Stastny, P., Katz, I., Mayer, M., & Mattis, S. A. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.2.230 · Cited by 110
Relationships between medication treatments and neuropsychological test performance in schizophrenia
Sweeney, J. A., Keilp, J. G., Haas, G. L., Hill, J., & Weiden, P. J. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90065-w · Cited by 90
Attentional Performance in Positive- and Negative-Symptom Schizophrenia
Green, M. M., & Walker, E. F. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198604000-00003 · Cited by 78
Positive and Negative Symptoms in Schizophrenia: Attentional Performance Correlates
Walker, E. F., & Harvey, P. D. (2010) · Psychopathology · doi:10.1159/000284452 · Cited by 53
Anticholinergic Effects on Memory
Gelenberg, A. J., Putten, T. V., Lavori, P. W., Wojcik, J., Falk, W. E., Marder, S. R., Galvin-Nadeau, M., Spring, B. J., Mohs, R. C., & Brotman, A. W. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198906000-00004 · Cited by 42
Anticholinergic effects on memory: benztropine versus amantadine.
Gelenberg, A. J., Putten, T. V., Lavori, P. W., Wojcik, J., Falk, W. E., Marder, S. R., Galvin-Nadeau, M., Spring, B. J., Mohs, R. C., & Brotman, A. W. (1989) · PubMed · Cited by 41
Greenblatt, D. J., Scavone, J. M., Harmatz, J. S., Engelhardt, N., & Shader, R. I. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.73 · Cited by 35
Sustained and selective attention in schizophrenia.
Mf, G., Kh, N., & Gaier, D. J. (1992) · PubMed · Cited by 13
Cited by
Memory Impairment in Schizophrenia: A Meta-Analysis
Aleman, A., Hijman, R., de Haan, E. H. F., & Kahn, R. S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1358 · Cited by 1,092
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Working Memory Impairments in Schizophrenia: A Meta-Analysis.
Lee, J., & Park, S. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.4.599 · Cited by 769
Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 693
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-06-01
- Volume
- 154
- Issue
- 6
- Pages
- 799-804
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2345907171
- Cited by
- 397
- References
- 32
- FWCI
- 28.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.